Research Excellence Award
Ranjith Kumavath – Pondicherry University
Ranjith Kumavath of Pondicherry University is a researcher whose scholarly activities are associated with the field of drug repurposing, an interdisciplinary area that integrates pharmaceutical sciences, molecular biology, computational approaches, and translational medicine. This article presents a structured academic overview prepared in the style of a scholarly reference entry, highlighting research profile indicators, publication activity, research impact metrics, and considerations relevant to recognition through the Research Excellence Award at the International Top Pharmaceutical Awards.[1]
Abstract
This academic profile summarizes the scholarly record of Ranjith Kumavath, emphasizing research productivity, citation performance, and contributions within the domain of drug repurposing. Available bibliometric indicators indicate sustained publication activity and measurable scholarly influence through citations and an established h-index. The profile further examines research relevance, interdisciplinary engagement, and potential alignment with the objectives commonly associated with scientific recognition programs and research excellence awards.[1][2]
Keywords
Drug Repurposing; Pharmaceutical Research; Translational Medicine; Research Impact; Bibliometrics; Scopus; Scientific Publications; Citation Analysis; Academic Recognition; Research Excellence.
Introduction
Drug repurposing has emerged as an important strategy in modern pharmaceutical research due to its potential to identify new therapeutic applications for existing compounds while reducing development timelines and associated costs. Researchers working in this area frequently integrate experimental and computational methodologies to evaluate candidate molecules, biological targets, and disease mechanisms. Within this context, the academic record of Ranjith Kumavath reflects engagement with topics relevant to pharmaceutical innovation and translational research.[3]
Research Profile
According to the reported bibliometric indicators, the researcher has accumulated 98 indexed documents, 1,927 citations, and an h-index of 25. These indicators are commonly used to evaluate scholarly productivity and the influence of published work within academic literature.[1]
Research Contributions
The researcher’s contributions are associated with investigations involving therapeutic discovery, molecular mechanisms of disease, computational screening approaches, and the identification of alternative clinical applications for existing pharmaceutical compounds. Such work contributes to broader scientific efforts aimed at improving therapeutic efficiency and expanding treatment opportunities through evidence-based repurposing strategies.[3][2]
Publications
Publication activity constitutes an important component of academic evaluation. The available metrics indicate a substantial body of indexed scholarly work. Representative literature within the broader field of drug repurposing demonstrates the significance of systematic approaches for identifying therapeutic opportunities and validating candidate compounds through experimental and computational frameworks.[3]
Research Impact
Bibliometric indicators suggest that the researcher’s publications have been cited by subsequent scholarly works, indicating engagement with the scientific community and continued relevance within ongoing research discussions. Citation counts and h-index values are commonly considered alongside qualitative assessments when evaluating academic impact and research influence.[1][2]
Award Suitability
Academic awards commonly consider factors such as publication productivity, citation influence, research originality, interdisciplinary engagement, and contributions to scientific advancement. Based on the reported academic indicators, the profile demonstrates characteristics frequently reviewed during recognition processes. Final determinations regarding awards remain subject to the criteria, peer review procedures, eligibility requirements, and evaluation standards established by the awarding organization.[3]
Conclusion
Ranjith Kumavath’s academic profile reflects a documented record of research activity associated with drug repurposing and related pharmaceutical sciences. The available bibliometric indicators demonstrate established scholarly productivity and measurable citation impact. As a reference-style overview, this article summarizes key aspects of research performance, publication activity, and academic visibility relevant to scientific recognition and professional evaluation.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Ranjith Kumavath, Author ID 13907540500. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=13907540500
- ORCID. (n.d.). ORCID record for Ranjith Kumavath.
https://orcid.org/0000-0002-0751-5491
- P. V., Thomas, N. M., Ranjith, N. K., Muripiti, V., & Banothu, J. (n.d.). Pyrimidine derivatives as anti-HIV agents: Advances and structure–activity relationship insights.
https://www.sciencedirect.com/science/article/abs/pii/S002228602601639X